Skip to main content
Caplight Logo









Vector BioMed, Inc.

Vector BioMed, Inc.

Private
Gaithersburg, MarylandHealthcare & Life Scienceshttps://vectorbiomed.com/

Last Round

Series A

Jan 31, 2023

Total Funding Raised

$15M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Vector BioMed, Inc. is a biotechnology company that operates as a contract development and manufacturing organization (CDMO) specializing in providing high-quality lentiviral vectors for preclinical and GMP manufacturing to support the development of cell and gene therapies.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Clinical Trials, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Application

Keywords

CDMOlentiviral vectorgene therapy manufacturingcell and gene therapyCAR-T manufacturingviral vector CDMObiomanufacturingviral vector manufacturingGMP manufacturingcontract developmentgene therapy supply chainbiotech servicesassay developmentvector designbioprocessing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Vector BioMed, Inc. Comparables

Compare Vector BioMed, Inc. with similar companies based on industry and business-model similarity.

Vector BioMed, Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
ViroCell Biologics
91%
VIVEbiotech
87%
Genezen
85%

Vector BioMed, Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AJan 31, 2023

Key People

Founding team and executive leadership

Andrew Worden

Chief Technology Officer

Executive Team

Vector BioMed, Inc. Investors

Notable investors and investment history

Vector BioMed, Inc. investors
InvestorRounds
Viking Global InvestorsSeries A
Casdin CapitalSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 25, 2026

    Monthly visitors grew 87% MoM.

  • May 2, 2025

    Will exhibit at the ASGCT 2025 event.

Vector BioMed, Inc. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Vector BioMed, Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Vector BioMed, Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersGaithersburg, Maryland
Employee Range30
Year Founded2021
Last FundingJan 31, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?